The most frequent oncogenic drivers in NSCLC are the Kirsten rat sarcoma viral oncogene (KRAS), epidermal growth factor receptor, and anaplastic lymphoma kinase, whereas less common oncogenic driver aberrations involve ROS1, MET, and BRAF.2,3. Here, BRAF is linked to non-small cell lung carcinoma.